As per the attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
At the 27th AGM held on September 30, 2025, shareholders of Tyche Industries approved a major board restructuring. Mr. Sandeep Gokaraju was appointed as the new Managing Director for a 5-year term effective September 5, 2025, replacing his brother Mr. G. Ganesh Kumar, who was re-designated from Chairman and Managing Director to Executive Director. Mr. Satya Srinivas Uppalapati was appointed as a new Executive Director with over 30 years of pharmaceutical industry experience. Additionally, Mr. Srinivas Gelli was re-designated as a Non-Executive Independent Director, and Mrs. Penumatsa Vijaya Lakshmi was re-appointed as an Independent Director for a second 5-year term.
The change marks a family-led succession at the top, with the Gokaraju brothers now sharing executive responsibilities, which may provide continuity but concentrates decision-making within the promoter family. The addition of an experienced Executive Director and continued independent oversight should support governance stability.